Skip to main content
. 2020 Feb 20;71(9):2365–2374. doi: 10.1093/cid/ciz1210

Figure 6.

Figure 6.

Cumulative survival curves of all patients using intermediate-early 1 (IE-1) >100 as high cytomegalovirus cell-mediated immunity (CMV-CMI) (cutoff 1). CMV-CMI level (high/low) and clinically significant cytomegalovirus infection (CS-CMVi) were time-dependent variables in the cumulative survival curves. There was only 1 significant difference among the 4 groups of patients: low CMV-CMI with CS-CMVi vs low CMV-CMI without CS-CMVi (P = .003).